The release of IFNγ by CD8+ T cells is similarly affected by location of T cell entry point; however, its concentration is higher at the invasive front as shown in case B, which has higher IFNγ concentration compared to the core of tumor from case A. The gene discussed is IFNG; the disease is neoplasm.